Acousia Therapeutics GmbH: Hearing loss company Acousia Therapeutics: first patient with age-related hearing loss treated with ACOU085
TÜBINGEN, Germany, May 5, 2022 /PRNewswire/ -- ACOU085, the lead candidate from Acousia Therapeutics, has been administered to the first patient with age-related hearing loss (presbycusis) in
Kostenloser Wertpapierhandel Tim Boelke Department Of Otolaryngology Head Neck Surgery Of The University Acousia Therapeutics German Bfarm
Source: finanznachrichten.de